| Welcome | Share your poster with the scientific world!Welcome to ePosters.net, the free online journal where you can share your scientific or medical poster with the world. After you present your poster at a conference or meeting you why not upload it here at ePosters.net? ePosters.net incorporates an advanced new search engine which scans all the words within the pdf allowing relevant posters to be quickly and accurately identified by researchers. Benefits of submitting your poster: - Easy and free - both submission and access are completely free of charge*
- Citation - you can cite your poster by its unique reference number and date on your résumé
- Worldwide exposure – access to your work is no longer restricted to just meeting attendees
- Easy to find - your poster can always be found using keywords or its unique reference number
- Increase collaboration - readers can contact you to discuss your work via anonymous email
- No loss of copyright – we do not require you to assign us any copyright on your material
- Reduce admin – interested viewers can print out your poster locally on their own printer
* For commercial companies there will be an administration charge of $200 for each poster published. Please contact Kelly Ruscoe for more information ePosters.net is now accepting submissions Sponsorship Opportunities We want the service provided by ePosters.net to be always available free of charge, thereby the ensuring widest possible sharing of new scientific work across the globe. Of course the vast potential audience for this facility should be of interest to sponsoring companies who wish to assist in the support of this service to the scientific community. For example : - Companies may wish to secure more exposure for the work (and investment) already expended in the preparation of their own posters. This can be facilitated by selecting the company name from the Sponsors drop down box on the home page.
- Conference organizers may wish to promote their meetings – over and above the free reciprocal arrangements we offer – by means of a banner ad either on the top of the home page or at the side of internal pages.
If you want to learn more about how your company could benefit from the opportunities available on ePosters.net please email us for more information. |
| | |
Genetic Algorithms Successfully Select Potential Biomarkers in Mass Spectrometry-Based Metabolomics
UC Davis Genome Center
Combination of the comprehensive metabolic profiling utilizing three complementary analytical methods for MS data acquisition and Genetic Algorithms technique for feature selection presenting intriguing avenue for finding and exploration small subsets of strong classifiers. |
Diagnostic Significance of microRNA Tumor Biomarkers in Fine Needle Aspirates (FNA) of Pancreatic Cancer
Asuragen, Inc., Dartmouth Medical School and Dartmouth Hitchcock Medical Center
Collection of pancreatic fine needle aspirates (FNAs) in RNARetain™ allows stabilization and protection of RNA in tissues containing high levels of nucleases; Differential miRNA expression in pancreatic FNAs accurately classifies benign and malignant tissue; Combinations of miRNA and mRNA expression signatures improve the separation between normal tissue and chronic pancreatitis; microRNAs are suitable analytes for molecular characterization of fine needle aspirates from pancreatic tissues. |
A high-throughput protein array-based approach
Centre for Proteomic and Genomic Research
Here we present a novel discovery-oriented high-throughput approach to the screening of allergen reactivates in crude biological extracts is presented using seafood allergens as an example. The CPGR workflow permits the effective screening of hundreds of putative allergens in parallel using minute amounts of patient serum and constitutes a cost-efficient allergen-specific antibody screening method for a routine diagnostic setting. |
Apoptosis Inducing Novel microRNA for Breast cancer and Hepatocellular Carcinoma
UC Davis Medical Center
MicroRNA provides a mechanism to target cancer stem cells and restraint tumors cells permanently; this could lead to promising cancer therapeutics and imaging agents. Apoptosis inducing microRNA was identified to target HCC and breast cancer cells for imaging and therapy. |
3D-QSAR Common Feature Pharmacophore Model for Polyphenols as Potential Anti-Malarial Agents
CDRI
3D QSAR studies have been carried out on a series of polyphenols for their antimalarial activity using CATALYST program. Hypothesis with three features namely hydrophobic (1), hydrogen bond donor (1) and hydrogen bond acceptor (1) was found to the best, which mapped well with the most active and least active compound of the test set. This model can be used to develop drugs for malarial chemotherapy. |
| | |
Protein Crystallographer
BioAlliance
La Jolla, CA, USA |
phD Scholarship in BioInformatics
Universitat Rovira i Virgili
Tarragona, Spain |
High Throughput Coordinator / Engineer
AJI
Houston, TX, USA |
BBSRC Funded Microfluidics Engineering Resarch PhD
University College London
London, UK |
Assistant Director, Automation Services
Medarex, Inc.
Milpitas, CA, USA |
Research Scientist II - Biology
Gilead Sciences
Foster City, CA, USA |
Permanent Senior Scientist Position in NMR-based Metabolomics
CIBERDEM
Tarragona, Spain |
QC Analyst
Genomic Health
Redwood City, CA, USA |
Research Chemist
Independent
Torrance, CA, USA |
Production Chemist II
Independent
Torrance, CA, USA |
Post-Doctpral Position in Mollusk Health Laboratory
UPEI
Charlottetown, Canada |
| | |
An Emerging Revolution in Automated 3D Cell Culture
Merck Research Laboratories,University of Virginia, BioCell Cubed
Market pressure exists for new paradigms to meet the demands for more rapid and reproducible cell production to keep up with advances in cell-based assays used in drug discovery and development. Novel automation platforms enable high productivity on three dimensional surfaces. |
Development of a Lab-on-a-Chip for the Characterization of Human Cells
ARC and Nano-Systemtechnologies
Cell chips are developed to continuously monitor mammalian cell population dynamics in a non-invasive manner. In the presented work we describe the design, fabrication and characterization of a lab-on-a-chip for quantitative cell analysis. |
RNA Interference in Mammalian Cells Using low siRNA Concentrations
QIAGEN
We have developed a transfection reagent, HiPerFect Transfection Reagent, which allows efficient gene knockdown with siRNA concentrations from 1 nM–10 nM, depending on the cell type and siRNA used. HiPerFect Transfection Reagent has been tested and validated for many cell types, including primary cells. Effective knockdown in primary cells demonstrates that HiPerFect Transfection Reagent ensures low cytotoxicity levels. |
Bio-analytic silicon chips for the detection of developmentalneurotoxic effects of chemicals and drugs in the context of the European REACH program
University of Rostock, Bionas GmbH
Bio-analytic silicon chips can be used to investigate stem cell differentiation into neurons and for the in vitro on-line monitoring of cellular reactions under well controlled experimental conditions. Chip systems allow for a parallel, label-free and non-invasive measurement of different parameters by CMOS silicon microsensors by the application of potential neurotoxic and developmental neurotoxic substances. |
|
|
|
|
| |
European Stem Cells & Regenerative Medicine Congress, London, UK
Terrapinn
Allowing you access the World's leading stem cell pioneers, ESCRM brings groundbreaking research, commercialisation and industry best practice to the fore. A strategic focus for stem cell research and regenerative medicine, expand your personal network of senior level industry contacts and be part of this year's most definitive learning experience. |
3rd Annual Biomarkers Congress,14 & 15 May 2008, Manchester, UK
Oxford Global
The conference programme will feature keynote addresses, case study presentations, panel and roundtable discussions from over 65 speakers in Biomarker Discovery and Validation, Molecular Diagnostics, Data Integration, Modelling and Bioinformatics, Imaging, Clinical Development and Toxicity Biomarkers. |
IBC’s TIDES®: Oligonucleotide and Peptide® Technology and Product Development, Las Vegas, NV, USA
IBC
TIDES® is the all encompassing conference on manufacturing, formulation, delivery, process and analytical development, as well as overall market trends for peptides and oligonucleotides. In addition to gaining scientific updates in conference sessions, you can develop and maintain your professional skills with two tracks focusing on oligos and peptides. |
Lead-Finding Screening, London, UK
IQPC
Enhance your lead discovery strategy and produce the quality leads you want by choosing the right assays and follow-up tools. |
Compound Management & Integrity 2008, London, UK
IQPC
The 5th annual Compound Management & Integrity conference will provide you with the most current issues facing Compound Managers, Screening and Analytics professionals. Presentations from big and medium size pharmas will give you the knowledge how to update your compound logistics, automation, QC and library for lead-finding success. |
InfoTech for Pharma & Biotech, Basel, Switzerland
Informa Life Sciences Group
Generating new science from data: The application of (bio) informatics tools to turn information into knowledge.
For more information visit: http://www.iir-events.com/IIR-Conf/page.aspx?id=10965
Or email: Kye-ling.gan@informa.com
Please Quote your VIP code: CQ7037PMBA |
Cell-Based Assays, Munich, Germany
Informa Life Sciences Group
The top line-up of expert speakers will share their latest thinking and experiences in cell-based assay design and implementation to provide you with new contacts and ideas that will help keep your assay platform at the forefront of cutting-edge technology, both in terms of usability and reliability. |
Emerging Regulatory Issues in Genomic Medicine, Mexico City, Mexico
Drug Information Association
The purpose of this meeting is to identify synergies and common issues in Genomic Medicine and to develop common approaches to address these issues. The FDA has a major effort in the area of genomics and personalized medicine. It is working with clinicians, the pharmaceutical industry, and other regulatory agencies worldwide to integrate genomic medicine into medical practice |
Personalised Medicine, London, UK
IQPC
Optimising the efficiency of your R&D strategy through effective investment into the tailored and personalised medicine arena. |
|
|